Cellect Biotechnology Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Cellect Biotechnology Ltd., a foreign private issuer, on January 10, 2020, covering the month of January 2020. The filing serves to disclose a material corporate governance event rather than financial results.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a corporate announcement and contains no financial data.
Material Changes
The primary material change disclosed is the resignation of Mr. Kasbian Nuriel Chirich. He stepped down from his positions as Chairman of the Board of Directors and Director, effective immediately on January 9, 2020.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future guidance, outlook, risks, contingencies, or unusual items. The company expressed gratitude for Mr. Chirich's service but provided no further operational details.
Key Facts for Investor Verification
- Mr. Kasbian Nuriel Chirich resigned as Chairman and Director effective January 9, 2020.
- The resignation was effective immediately.
- The filing was signed by Eyal Leibovitz, Chief Financial Officer, on January 10, 2020.
- No financial performance data is included in this specific filing.